Oscar Health (OSCR) to Release Earnings on Wednesday

Oscar Health (NYSE:OSCR) is expected to be announcing its earnings results before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $2.47 billion for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.29) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Performance

OSCR opened at $16.34 on Wednesday. Oscar Health has a twelve month low of $12.43 and a twelve month high of $23.79. The stock has a market cap of $4.04 billion, a PE ratio of -272.27, a price-to-earnings-growth ratio of 0.65 and a beta of 1.70. The business’s 50 day moving average is $15.20 and its 200-day moving average is $16.82. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Insider Buying and Selling

In other news, Vice Chairman Joshua Kushner bought 276,040 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were acquired at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now directly owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. The trade was a 5.80 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Victoria Baltrus sold 8,078 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Insiders own 25.11% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on OSCR. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Finally, Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.